[{"edinetCode":"E00961","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":694.0,"averageTemporaryStaff":286.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9714600.0,"sharesOwendPercent":0.4462,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":1656.98,"equityRatio":0.686,"cashAndCashEquivalents":6984000000.0,"assets":44252000000.0,"currentAssets":26983000000.0,"fixedAsset":17269000000.0,"tangibleFixedAssets":11689000000.0,"intangibleFixedAssets":499000000.0,"investmentAndOtherAssets":5080000000.0,"liabilities":13642000000.0,"currentLiabilities":12672000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":970000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":30609000000.0,"capitalStock":30265000000.0,"capital":6897000000.0,"capitalSurplus":7894000000.0,"accumulatedEarnings":18758000000.0,"treasuryStock":-3284000000.0,"valuationAndConversionAdjustments":80000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":33274000000.0,"costOfSales":19110000000.0,"grossProfit":14163000000.0,"sgaExpenses":10186000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2336000000.0,"operatingIncome":3976000000.0,"nonOperatingIncome":158000000.0,"nonOperatingExpenses":22000000.0,"interestExpense":9000000.0,"ordinaryProfit":4112000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":268000000.0,"incomeBeforeTax":3845000000.0,"incomeTaxes":926000000.0,"netIncome":2918000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2918000000.0,"comprehensiveIncome":3082000000.0,"eps":159.39,"dilutedEps":157.6,"dividendPerShare":null,"per":19.4,"roe":0.1,"cashFlowFromOperatingActivities":4701000000.0,"depreciationAndCashflowFromOperatingActivities":1563000000.0,"cashFlowFromInvestingActivities":-1876000000.0,"cashFlowFromFinancialActivities":-910000000.0,"changesInCashAndCashEquivalents":1909000000.0,"列1":"asr","submitDate":"2017\/6\/23","stockCode":4549,"accountingYear":"第79期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":704.0,"averageTemporaryStaff":312.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":9799400.0,"sharesOwendPercent":0.5349,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":877.35,"equityRatio":0.712,"cashAndCashEquivalents":6651000000.0,"assets":45165000000.0,"currentAssets":27197000000.0,"fixedAsset":17968000000.0,"tangibleFixedAssets":11391000000.0,"intangibleFixedAssets":435000000.0,"investmentAndOtherAssets":6140000000.0,"liabilities":12687000000.0,"currentLiabilities":11550000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1136000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":32478000000.0,"capitalStock":31876000000.0,"capital":6897000000.0,"capitalSurplus":7898000000.0,"accumulatedEarnings":20359000000.0,"treasuryStock":-3279000000.0,"valuationAndConversionAdjustments":269000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":34991000000.0,"costOfSales":20290000000.0,"grossProfit":14701000000.0,"sgaExpenses":11220000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3238000000.0,"operatingIncome":3478000000.0,"nonOperatingIncome":106000000.0,"nonOperatingExpenses":35000000.0,"interestExpense":8000000.0,"ordinaryProfit":3549000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":75000000.0,"incomeBeforeTax":3474000000.0,"incomeTaxes":865000000.0,"netIncome":2608000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2608000000.0,"comprehensiveIncome":2797000000.0,"eps":71.21,"dilutedEps":70.34,"dividendPerShare":null,"per":37.6,"roe":0.083,"cashFlowFromOperatingActivities":4091000000.0,"depreciationAndCashflowFromOperatingActivities":1660000000.0,"cashFlowFromInvestingActivities":-3250000000.0,"cashFlowFromFinancialActivities":-1175000000.0,"changesInCashAndCashEquivalents":-332000000.0,"列1":"asr","submitDate":"2018\/6\/27","stockCode":4549,"accountingYear":"第80期（自　2017年４月１日　至　2018年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":719.0,"averageTemporaryStaff":321.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20129000.0,"sharesOwendPercent":0.5458,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":942.37,"equityRatio":0.735,"cashAndCashEquivalents":4448000000.0,"assets":47279000000.0,"currentAssets":25852000000.0,"fixedAsset":21427000000.0,"tangibleFixedAssets":11095000000.0,"intangibleFixedAssets":744000000.0,"investmentAndOtherAssets":9587000000.0,"liabilities":12265000000.0,"currentLiabilities":10981000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1284000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":35014000000.0,"capitalStock":34537000000.0,"capital":6897000000.0,"capitalSurplus":7935000000.0,"accumulatedEarnings":22869000000.0,"treasuryStock":-3165000000.0,"valuationAndConversionAdjustments":219000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":35761000000.0,"costOfSales":20069000000.0,"grossProfit":15692000000.0,"sgaExpenses":11080000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":2904000000.0,"operatingIncome":4611000000.0,"nonOperatingIncome":100000000.0,"nonOperatingExpenses":30000000.0,"interestExpense":7000000.0,"ordinaryProfit":4681000000.0,"extraordinaryGain":98000000.0,"extraordinaryLoss":130000000.0,"incomeBeforeTax":4649000000.0,"incomeTaxes":1201000000.0,"netIncome":3447000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3447000000.0,"comprehensiveIncome":3397000000.0,"eps":93.63,"dilutedEps":92.84,"dividendPerShare":null,"per":27.8,"roe":0.103,"cashFlowFromOperatingActivities":3318000000.0,"depreciationAndCashflowFromOperatingActivities":1594000000.0,"cashFlowFromInvestingActivities":-4435000000.0,"cashFlowFromFinancialActivities":-1083000000.0,"changesInCashAndCashEquivalents":-2202000000.0,"列1":"asr","submitDate":"2019\/6\/26","stockCode":4549,"accountingYear":"第81期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.748,"cashAndCashEquivalents":null,"assets":47099000000.0,"currentAssets":25365000000.0,"fixedAsset":21733000000.0,"tangibleFixedAssets":11238000000.0,"intangibleFixedAssets":942000000.0,"investmentAndOtherAssets":9552000000.0,"liabilities":11599000000.0,"currentLiabilities":10348000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1250000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":35499000000.0,"capitalStock":35041000000.0,"capital":6897000000.0,"capitalSurplus":7935000000.0,"accumulatedEarnings":23374000000.0,"treasuryStock":-3165000000.0,"valuationAndConversionAdjustments":182000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":9232000000.0,"costOfSales":5088000000.0,"grossProfit":4143000000.0,"sgaExpenses":2652000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1490000000.0,"nonOperatingIncome":25000000.0,"nonOperatingExpenses":2000000.0,"interestExpense":1000000.0,"ordinaryProfit":1514000000.0,"extraordinaryGain":5000000.0,"extraordinaryLoss":8000000.0,"incomeBeforeTax":1510000000.0,"incomeTaxes":379000000.0,"netIncome":1131000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1131000000.0,"comprehensiveIncome":1095000000.0,"eps":30.68,"dilutedEps":30.46,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4549,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":18738100.0,"sharesOwendPercent":0.5081,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.74,"cashAndCashEquivalents":5966000000.0,"assets":49161000000.0,"currentAssets":27667000000.0,"fixedAsset":21493000000.0,"tangibleFixedAssets":11057000000.0,"intangibleFixedAssets":957000000.0,"investmentAndOtherAssets":9478000000.0,"liabilities":12473000000.0,"currentLiabilities":11196000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1277000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":36687000000.0,"capitalStock":36254000000.0,"capital":6897000000.0,"capitalSurplus":7935000000.0,"accumulatedEarnings":24587000000.0,"treasuryStock":-3165000000.0,"valuationAndConversionAdjustments":145000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":18917000000.0,"costOfSales":10546000000.0,"grossProfit":8370000000.0,"sgaExpenses":5326000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1267000000.0,"operatingIncome":3043000000.0,"nonOperatingIncome":68000000.0,"nonOperatingExpenses":10000000.0,"interestExpense":2000000.0,"ordinaryProfit":3101000000.0,"extraordinaryGain":33000000.0,"extraordinaryLoss":11000000.0,"incomeBeforeTax":3124000000.0,"incomeTaxes":780000000.0,"netIncome":2344000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2344000000.0,"comprehensiveIncome":2270000000.0,"eps":63.56,"dilutedEps":63.09,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":3269000000.0,"depreciationAndCashflowFromOperatingActivities":779000000.0,"cashFlowFromInvestingActivities":-1059000000.0,"cashFlowFromFinancialActivities":-687000000.0,"changesInCashAndCashEquivalents":1518000000.0,"列1":"q2r","submitDate":"2019\/11\/11","stockCode":4549,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.754,"cashAndCashEquivalents":null,"assets":49008000000.0,"currentAssets":26765000000.0,"fixedAsset":22242000000.0,"tangibleFixedAssets":11846000000.0,"intangibleFixedAssets":982000000.0,"investmentAndOtherAssets":9413000000.0,"liabilities":11744000000.0,"currentLiabilities":10424000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1319000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":37263000000.0,"capitalStock":36765000000.0,"capital":6897000000.0,"capitalSurplus":7935000000.0,"accumulatedEarnings":25098000000.0,"treasuryStock":-3165000000.0,"valuationAndConversionAdjustments":195000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":28028000000.0,"costOfSales":15536000000.0,"grossProfit":12492000000.0,"sgaExpenses":8142000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":4349000000.0,"nonOperatingIncome":83000000.0,"nonOperatingExpenses":12000000.0,"interestExpense":3000000.0,"ordinaryProfit":4420000000.0,"extraordinaryGain":33000000.0,"extraordinaryLoss":12000000.0,"incomeBeforeTax":4441000000.0,"incomeTaxes":1106000000.0,"netIncome":3335000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3335000000.0,"comprehensiveIncome":3311000000.0,"eps":90.43,"dilutedEps":89.74,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/10","stockCode":4549,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":724.0,"averageTemporaryStaff":329.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":17646000.0,"sharesOwendPercent":0.4784,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":1002.86,"equityRatio":0.735,"cashAndCashEquivalents":4981000000.0,"assets":50322000000.0,"currentAssets":28903000000.0,"fixedAsset":21418000000.0,"tangibleFixedAssets":12041000000.0,"intangibleFixedAssets":1019000000.0,"investmentAndOtherAssets":8357000000.0,"liabilities":13018000000.0,"currentLiabilities":11740000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1278000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":37303000000.0,"capitalStock":36969000000.0,"capital":6897000000.0,"capitalSurplus":7935000000.0,"accumulatedEarnings":25302000000.0,"treasuryStock":-3165000000.0,"valuationAndConversionAdjustments":17000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":36585000000.0,"costOfSales":20355000000.0,"grossProfit":16229000000.0,"sgaExpenses":11608000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3332000000.0,"operatingIncome":4622000000.0,"nonOperatingIncome":115000000.0,"nonOperatingExpenses":14000000.0,"interestExpense":4000000.0,"ordinaryProfit":4723000000.0,"extraordinaryGain":33000000.0,"extraordinaryLoss":32000000.0,"incomeBeforeTax":4724000000.0,"incomeTaxes":1185000000.0,"netIncome":3538000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3538000000.0,"comprehensiveIncome":3337000000.0,"eps":95.95,"dilutedEps":95.21,"dividendPerShare":null,"per":20.5,"roe":0.099,"cashFlowFromOperatingActivities":5460000000.0,"depreciationAndCashflowFromOperatingActivities":1627000000.0,"cashFlowFromInvestingActivities":-3711000000.0,"cashFlowFromFinancialActivities":-1220000000.0,"changesInCashAndCashEquivalents":532000000.0,"列1":"asr","submitDate":"2020\/6\/24","stockCode":4549,"accountingYear":"第82期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.757,"cashAndCashEquivalents":null,"assets":49105000000.0,"currentAssets":27694000000.0,"fixedAsset":21411000000.0,"tangibleFixedAssets":11969000000.0,"intangibleFixedAssets":1092000000.0,"investmentAndOtherAssets":8348000000.0,"liabilities":11643000000.0,"currentLiabilities":10379000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1264000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":37462000000.0,"capitalStock":37131000000.0,"capital":6897000000.0,"capitalSurplus":7950000000.0,"accumulatedEarnings":25439000000.0,"treasuryStock":-3155000000.0,"valuationAndConversionAdjustments":25000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":8214000000.0,"costOfSales":4639000000.0,"grossProfit":3574000000.0,"sgaExpenses":2558000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1016000000.0,"nonOperatingIncome":18000000.0,"nonOperatingExpenses":3000000.0,"interestExpense":0.0,"ordinaryProfit":1031000000.0,"extraordinaryGain":null,"extraordinaryLoss":4000000.0,"incomeBeforeTax":1027000000.0,"incomeTaxes":263000000.0,"netIncome":764000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":764000000.0,"comprehensiveIncome":772000000.0,"eps":20.72,"dilutedEps":20.55,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/7","stockCode":4549,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":18206700.0,"sharesOwendPercent":0.493,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.765,"cashAndCashEquivalents":3922000000.0,"assets":50460000000.0,"currentAssets":27873000000.0,"fixedAsset":22587000000.0,"tangibleFixedAssets":11987000000.0,"intangibleFixedAssets":1124000000.0,"investmentAndOtherAssets":9475000000.0,"liabilities":11571000000.0,"currentLiabilities":10271000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1299000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":38889000000.0,"capitalStock":38556000000.0,"capital":6897000000.0,"capitalSurplus":7973000000.0,"accumulatedEarnings":26827000000.0,"treasuryStock":-3142000000.0,"valuationAndConversionAdjustments":55000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":17727000000.0,"costOfSales":9774000000.0,"grossProfit":7953000000.0,"sgaExpenses":5228000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1338000000.0,"operatingIncome":2724000000.0,"nonOperatingIncome":74000000.0,"nonOperatingExpenses":4000000.0,"interestExpense":1000000.0,"ordinaryProfit":2794000000.0,"extraordinaryGain":110000000.0,"extraordinaryLoss":27000000.0,"incomeBeforeTax":2877000000.0,"incomeTaxes":725000000.0,"netIncome":2151000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":2151000000.0,"comprehensiveIncome":2190000000.0,"eps":58.31,"dilutedEps":57.86,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":903000000.0,"depreciationAndCashflowFromOperatingActivities":798000000.0,"cashFlowFromInvestingActivities":-1287000000.0,"cashFlowFromFinancialActivities":-676000000.0,"changesInCashAndCashEquivalents":-1059000000.0,"列1":"q2r","submitDate":"2020\/11\/11","stockCode":4549,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.766,"cashAndCashEquivalents":null,"assets":52545000000.0,"currentAssets":29682000000.0,"fixedAsset":22862000000.0,"tangibleFixedAssets":12206000000.0,"intangibleFixedAssets":1334000000.0,"investmentAndOtherAssets":9321000000.0,"liabilities":12031000000.0,"currentLiabilities":10770000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1260000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":40513000000.0,"capitalStock":40135000000.0,"capital":6897000000.0,"capitalSurplus":7973000000.0,"accumulatedEarnings":28406000000.0,"treasuryStock":-3142000000.0,"valuationAndConversionAdjustments":91000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":28547000000.0,"costOfSales":15026000000.0,"grossProfit":13521000000.0,"sgaExpenses":7989000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":5531000000.0,"nonOperatingIncome":136000000.0,"nonOperatingExpenses":11000000.0,"interestExpense":2000000.0,"ordinaryProfit":5656000000.0,"extraordinaryGain":110000000.0,"extraordinaryLoss":43000000.0,"incomeBeforeTax":5723000000.0,"incomeTaxes":1438000000.0,"netIncome":4284000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4284000000.0,"comprehensiveIncome":4359000000.0,"eps":116.08,"dilutedEps":115.2,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4549,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":733.0,"averageTemporaryStaff":354.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":18739100.0,"sharesOwendPercent":0.5074,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":1120.36,"equityRatio":0.743,"cashAndCashEquivalents":6968000000.0,"assets":55685000000.0,"currentAssets":29983000000.0,"fixedAsset":25701000000.0,"tangibleFixedAssets":12768000000.0,"intangibleFixedAssets":1450000000.0,"investmentAndOtherAssets":11481000000.0,"liabilities":14012000000.0,"currentLiabilities":12772000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1239000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":41672000000.0,"capitalStock":40895000000.0,"capital":6897000000.0,"capitalSurplus":7973000000.0,"accumulatedEarnings":29166000000.0,"treasuryStock":-3142000000.0,"valuationAndConversionAdjustments":479000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":38667000000.0,"costOfSales":20137000000.0,"grossProfit":18529000000.0,"sgaExpenses":11914000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":3086000000.0,"operatingIncome":6612000000.0,"nonOperatingIncome":220000000.0,"nonOperatingExpenses":24000000.0,"interestExpense":2000000.0,"ordinaryProfit":6808000000.0,"extraordinaryGain":110000000.0,"extraordinaryLoss":48000000.0,"incomeBeforeTax":6870000000.0,"incomeTaxes":1825000000.0,"netIncome":5044000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5044000000.0,"comprehensiveIncome":5507000000.0,"eps":136.65,"dilutedEps":135.6,"dividendPerShare":null,"per":15.8,"roe":0.129,"cashFlowFromOperatingActivities":5451000000.0,"depreciationAndCashflowFromOperatingActivities":1711000000.0,"cashFlowFromInvestingActivities":-2193000000.0,"cashFlowFromFinancialActivities":-1275000000.0,"changesInCashAndCashEquivalents":1987000000.0,"列1":"asr","submitDate":"2021\/6\/23","stockCode":4549,"accountingYear":"第83期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.767,"cashAndCashEquivalents":null,"assets":54621000000.0,"currentAssets":27125000000.0,"fixedAsset":27496000000.0,"tangibleFixedAssets":14153000000.0,"intangibleFixedAssets":1466000000.0,"investmentAndOtherAssets":11876000000.0,"liabilities":12446000000.0,"currentLiabilities":11172000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1273000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":42175000000.0,"capitalStock":41402000000.0,"capital":6897000000.0,"capitalSurplus":7984000000.0,"accumulatedEarnings":29657000000.0,"treasuryStock":-3138000000.0,"valuationAndConversionAdjustments":482000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":10514000000.0,"costOfSales":5303000000.0,"grossProfit":5210000000.0,"sgaExpenses":2618000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":2592000000.0,"nonOperatingIncome":42000000.0,"nonOperatingExpenses":1000000.0,"interestExpense":0.0,"ordinaryProfit":2633000000.0,"extraordinaryGain":0.0,"extraordinaryLoss":0.0,"incomeBeforeTax":2633000000.0,"incomeTaxes":658000000.0,"netIncome":1974000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":1974000000.0,"comprehensiveIncome":1977000000.0,"eps":53.47,"dilutedEps":53.06,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/6","stockCode":4549,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":20045700.0,"sharesOwendPercent":0.5423,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.759,"cashAndCashEquivalents":6329000000.0,"assets":57455000000.0,"currentAssets":31159000000.0,"fixedAsset":26296000000.0,"tangibleFixedAssets":14056000000.0,"intangibleFixedAssets":1425000000.0,"investmentAndOtherAssets":10814000000.0,"liabilities":13566000000.0,"currentLiabilities":12281000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":1285000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":43888000000.0,"capitalStock":43121000000.0,"capital":6897000000.0,"capitalSurplus":8000000000.0,"accumulatedEarnings":31348000000.0,"treasuryStock":-3126000000.0,"valuationAndConversionAdjustments":487000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":21341000000.0,"costOfSales":11085000000.0,"grossProfit":10255000000.0,"sgaExpenses":5424000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":1411000000.0,"operatingIncome":4831000000.0,"nonOperatingIncome":68000000.0,"nonOperatingExpenses":2000000.0,"interestExpense":0.0,"ordinaryProfit":4897000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":7000000.0,"incomeBeforeTax":4891000000.0,"incomeTaxes":1224000000.0,"netIncome":3666000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":3666000000.0,"comprehensiveIncome":3673000000.0,"eps":99.23,"dilutedEps":98.5,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":3353000000.0,"depreciationAndCashflowFromOperatingActivities":973000000.0,"cashFlowFromInvestingActivities":-2992000000.0,"cashFlowFromFinancialActivities":-1000000000.0,"changesInCashAndCashEquivalents":-639000000.0,"列1":"q2r","submitDate":"2021\/11\/10","stockCode":4549,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0},{"edinetCode":"E00961","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.738,"cashAndCashEquivalents":null,"assets":60008000000.0,"currentAssets":32535000000.0,"fixedAsset":27473000000.0,"tangibleFixedAssets":15267000000.0,"intangibleFixedAssets":1384000000.0,"investmentAndOtherAssets":10821000000.0,"liabilities":15429000000.0,"currentLiabilities":11174000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4254000000.0,"bonds":3000000000.0,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":44579000000.0,"capitalStock":43752000000.0,"capital":6897000000.0,"capitalSurplus":8000000000.0,"accumulatedEarnings":31979000000.0,"treasuryStock":-3126000000.0,"valuationAndConversionAdjustments":528000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":31831000000.0,"costOfSales":16772000000.0,"grossProfit":15058000000.0,"sgaExpenses":8415000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":6643000000.0,"nonOperatingIncome":127000000.0,"nonOperatingExpenses":29000000.0,"interestExpense":4000000.0,"ordinaryProfit":6740000000.0,"extraordinaryGain":1000000.0,"extraordinaryLoss":23000000.0,"incomeBeforeTax":6718000000.0,"incomeTaxes":1682000000.0,"netIncome":5036000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5036000000.0,"comprehensiveIncome":5085000000.0,"eps":136.29,"dilutedEps":135.28,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/10","stockCode":4549,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00961","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":6897,"settlementDate":"2022\/3\/31","submitterName":"栄研化学株式会社","submitterNameEnglish":"EIKEN CHEMICAL CO.,LTD.","submitterNameKana":"エイケンカガクカブシキガイシャ","location":"台東区台東四丁目１９番９号","industory":"医薬品","corporateNumber":2010000000000.0}]